` Comparison: NEO, 207940 - Alpha Spread

NEO
vs
207940

Over the past 12 months, NEO has underperformed Samsung Biologics Co Ltd, delivering a return of -64% compared to the Samsung Biologics Co Ltd's +9% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NEO
207940
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NEO Intrinsic Value
13.73 USD
Undervaluation 58%
Intrinsic Value
Price
Intrinsic Value
671 351.94 KRW
Overvaluation 35%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Neogenomics Inc
NASDAQ:NEO
5.8 USD
Samsung Biologics Co Ltd
KRX:207940
1 031 000 KRW
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NEO, 207940

NEO
207940
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Neogenomics Inc
Revenue
Samsung Biologics Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
NEO, 207940

NEO
207940
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Neogenomics Inc
NASDAQ:NEO
Samsung Biologics Co Ltd
KRX:207940
What is Free Cash Flow?

Gross Margin

NEO
43.9%
Samsung Biologics Co Ltd
53.2%

Operating Margin

NEO
-13.4%
Samsung Biologics Co Ltd
32.4%

Net Margin

NEO
-15.1%
Samsung Biologics Co Ltd
26.1%

FCF Margin

NEO
-2.8%
Samsung Biologics Co Ltd
2.8%

ROE

NEO
-11.8%
Samsung Biologics Co Ltd
12%

ROA

NEO
-6.9%
Samsung Biologics Co Ltd
7.5%

ROIC

NEO
-7.5%
Samsung Biologics Co Ltd
8.2%

ROCE

NEO
-7%
Samsung Biologics Co Ltd
12.3%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
NEO, 207940

Loading

Performance Gap
NEO, 207940

Loading
NEO
207940
Difference
www.alphaspread.com

Performance By Year
NEO, 207940

Loading
NEO
207940
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NEO to other stocks
Unlock Full Access to Alpha Spread
Create Free Account